Patients with squamous cell carcinoma of the head and neck were randomly assigned to receive either intensity-modulated radiotherapy with weekly cetuximab or radiotherapy alone.

During the past decades, treatment of laryngeal cancer has changed substantially, mainly due to the advent of novel approaches such as combined modality therapy as well as improvements in ...

"Based on data from the eight eligible studies from 2019 to 2023, the committee concludes that compared with never consuming ...

Baseline alcohol intake as well as lifetime alcohol consumption were associated with an increased risk of the development of squamous cell carcinoma, basal cell carcinoma, and melanoma in men ...

Results from the Phase III NRG Oncology RTOG 0920 (NRG-RTOG 0920) trial assessing postoperative radiotherapy with or without ...

head and neck cancer squamous cell carcinoma, gastroesophageal (ge) junction carcinomas, oral cavity (mouth) cancer, oropharyngeal cancer, hypopharyngeal cancer, nasopharyngeal cancer, laryngeal ...

head and squamous cell carcinoma, oropharyngeal cancer, hypopharyngeal cancer, oral cavity cancer and laryngeal cancer. The drug candidate is a bi-specific monoclonal antibody. It is administered ...

or larynx. Squamous cell carcinoma of the head and neck must have been treated by primary surgery, Patients must also have had a history of alcohol consumption and smoking, complete macroscopic ...

Show Full Article The direct link between alcohol consumption and cancer risk is well-established for at least seven types of cancers, of the colorectum, oesophagus, liver, mouth (oral cavity), throat ...

Eligible patients were aged 18 years or older with stage III to IVB p16-negative squamous cell carcinoma of the larynx, hypopharynx, oropharynx, oral cavity, or unknown primary HNSCC, or unfavorable ...